Jinxin Fertility Group Limited (HKG:1951)

Market Cap	7.79B
Revenue (ttm)	2.91B
Net Income (ttm)	-1.04B
Shares Out	2.74B
EPS (ttm)	-0.39
PE Ratio	n/a
Forward PE	20.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,001,500
Average Volume	45,947,746
Open	2.850
Previous Close	2.840
Day's Range	2.820 - 2.870
52-Week Range	2.350 - 4.640
Beta	1.37
RSI	48.96
Earnings Date	Nov 25, 2025

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psycholo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,198
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY